CS
MRUS

Candriam SCA’s Merus MRUS Stock Holding History

Candriam SCA’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-49
Closed -$1K – 805
2022
Q1 		$1K Buy
+49
New +$1.31K ﹤0.01% 801
2021
Q4 		– Sell
-47
Closed -$1K – 845
2021
Q3 		$1K Buy
47
+3
+7% +$64 ﹤0.01% 872
2021
Q2 		$1K Buy
+44
New +$973 ﹤0.01% 875

Other funds holding MRUS

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Candriam SCA's MRUS Position: Q2 2022 in Review

Candriam SCA sold out of Merus (MRUS) in Q2 2022, closing a stake of 49 shares — an estimated $1K sold.

Candriam SCA first reported a position in MRUS in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 93 funds tracked by Wall St. Rank hold MRUS as of Q2 2022.

  • Candriam SCA reported no remaining Merus position as of Q2 2022 after selling out during the quarter.
  • Candriam SCA sold 49 Merus shares in Q2 2022, an estimated $1K.
  • Candriam SCA first reported a position in Merus in Q2 2021 and held it in 3 quarters.
  • Candriam SCA's Merus position peaked at $1K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Merus as of Q2 2022.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.